Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Covington Advises Charles Stanley Securities and WG Partners on the Admission to AIM of Venture Life Group plc

March 28, 2014

LONDON, 28 March, 2014 — Covington & Burling advised Charles Stanley Securities acting as nominated adviser and WG Partners acting as financial adviser and broker to Venture Life Group plc, the international consumer healthcare company, on its admission to AIM.

On admission to AIM, Venture Life will complete the acquisition of Biokosmes Srl, an Italian company which develops and manufactures topical products, including cosmetics, dermo-cosmetics and medical devices.

The proceeds of the placing will be used to satisfy the initial consideration payable for the acquisition of Biokosmes, as well as to fund the strengthening of Venture Life’s commercial team, new product development, and collaboration projects, particularly in China and the Far East. The market capitalisation of the company at admission will be £26.4 million.

The Covington team was led by partner Natalie Walter and was assisted by partner Kristian Wiggert and associate Sarah Hoult.

Share this article: